期刊文献+

2,N-二甲基-N-(3,3-二苯基丙基)-1-氨基-2-丙醇的合成 被引量:2

Synthesis of 2,N-dimethyl-N-(3,3-diphenylpropyl)-1-amino-2-propanol
下载PDF
导出
摘要 目的研究 2 ,N 二甲基 N (3 ,3 二苯基丙基 ) 1 氨基 2 丙醇 (1 )的合成方法。方法以肉桂酸、氯化亚砜、甲胺等为原料 ,经烃化、氯化、酰化和还原反应得到N 甲基 3 ,3 二苯基丙胺 (5 ) ;以 3 氯异丁烯为原料 ,经加成、水解、环合反应得到环氧异丁烷 (7) ,化合物 5与 7经烃化反应得到目标产物。结果与结论设计的合成路线以肉桂酸计 ,5步反应总收率为 62 7% ,合成路线简便易行 ,适于大规模制备。所合成的目标产物经ESI MS和1H NMR确证。 Aim To investigate a method for the synthesis of 2,N -dimethyl- N -(3,3-diphenylpropyl)-1-amino-2-propanol( 1 ). Methods Alkylation of benzene with cinnamic acid via the Fridel-Crafts reaction gave 3,3- diphenylpropanoic acid,which was subsequently converted to the corresponding acid chloride,then reacted with dried methylamine to obtain N -methyl-3,3-diphenylpropanamide in dichloromethane.This amide was efficiently reduced with the NaBH_4-CH_3COOH/THF system,and the key intermediate N -methyl-3,3-diphenylpropanamine( 5 )was provided in 90% yield.Then 3-chloroisopropene was treated with 80% sulfuric acid followed by hydrolysis to give 1-chloro-2-methyl-2-propanol,which was effected with 7.5 mol/L NaOH using TEBA as a catalyst to provide another key intermediate isobutylene oxide( 7 ).Finally,5 reacted with 7 under refluxing for 12 h without adding a solvent to gain the target molecule in near quantity. Results and conclusion A cost-efficient facile synthetic route that is suitable for large-scale preparation of the target compound has been provided through a five-step procedure starting from cinnamic acid in a total yield of 62.7%,and the structure was verified by ESI-MS and 1H-NMR.
出处 《中国药物化学杂志》 CAS CSCD 2004年第1期30-32,共3页 Chinese Journal of Medicinal Chemistry
关键词 药物化学 制备 化学合成 2 N-二甲基-N-(3 3-二苯基丙基)-1-氨基-2-丙醇 乐卡地平 medicinal chemistry preparation chemical synthesis 2,N-dimethyl-N-(3,3-diphenylpropyl)-1-amino-2-propanol lercanidipine
  • 相关文献

参考文献2

  • 1全国原料药生产工艺汇编编写组.全国原料药生产工艺汇编[M].上海:中国医药工业出版社,1979.440-442.
  • 2孙忠实,朱珠.乐卡地平[J].中国新药杂志,2001,10(7):545-546. 被引量:8

二级参考文献2

  • 1[1]McClellan KJ,Jar B.Lercanidipine,a review of its use in hypertension[J].Drugs,2000,60(5)∶1123-1240.
  • 2[2]Sabbatini M,Vitaioli L,Baldoni E,et al.Nephroprotective effect of treatment with calcium channel blockers in spontaneously hypertensive rats[J].J Pharmacol Exp Ther,2000,294(3)∶948-954.

共引文献7

同被引文献43

  • 1王巍.药品行政保护品种介绍:心血管药物(二)(续完)[J].中国新药与临床杂志,2005,24(3):229-230. 被引量:2
  • 2廖国平,高瑞昶,张广明,张津枫.盐酸乐卡地平的合成[J].精细化工,2005,22(12):950-951. 被引量:5
  • 3KANSARA R,PATEL N, REHANI R,et al. A process for the preparation of 1,4-dihydropyridine-3,5-dicarboxylic acid derivative:WO, 2005/107374 A2 [ P ]. 2005 - 11 - 17.
  • 4REDDY P,REDDY R,REDDY M. A novel process for the preparation of Lercanidipine :WO ,2006/134606 A1 [ P]. 2006 - 12 - 21.
  • 5TOMER Z. Intermediates for the preparation of Lercanidipine: WO ,2006/059332 A1 [ P]. 2006 -06 -08.
  • 6CORSINI A, ACCOMAZZO MR, CANAVESI M. et al. The new calcium antagonist lercan-idiplne and its enantiomers affect major processes of atherogenesis in vitro: is calcium entry involved ? [ J ]. Blood Press Suppl, 1998,7 ( 2 ) : 18 - 22.
  • 7CORSINI A, BONFATTI M, QUARATO P,et al. Effect of the new calcium antagonist lercanidiplne and its enantiomers on the migration and proliferation of arterial myocytes [ J ]. J Cardlovasc Pharmacol, 1996,28 (5) :687 - 694.
  • 8SABBATINI M, LEONARDI A, TESTA R, et al. Effects of dihydropyridine-type Ca^2 + antagonists on the renal arterial tree in spontaneously hypertensive rats [ J ] . J Cardlovasc Pharmacol, 2002,39(1) :39 -48.
  • 9SABBATINI M, VITAIOLI L, BALDONI E, et al. Nephroprotecrive effect of treatment with calcium channel blockers in spontaneously hypertensive rats [ J ]. J Pharmacol Exp Ther , 2000,294 (3) :948 - 954.
  • 10SABBATINI M, LEONARDI A ,TESTA R ,et al. Effect of calcium antagonists on glom-erular arterioles in spontaneously hypertensive rats [ J ]. Hypertension, 2000,35 ( 3 ) : 775 - 779.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部